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CONTROL OF RATS RESISTANT TO SECOND-GENERATION ANTICOAGULANT
RODENTICIDES
ROGER J. QUY, ALAN D. M A C N I C O L L , and DAVID P. COWAN, Central Science Laboratory (MAFF), Sand
Hutton, York, YO4 1LZ, United Kingdom.
ABSTRACT: Second-generation anticoagulant rodenticides were introduced to control Norway rats that had become
resistant to first-generation compounds. Unfortunately, some rats have become resistant to these as well. The lack of
alternative rodenticides with the same attributes of ease of use and relative safety is potentially a serious problem should
resistance become so widespread that anticoagulants are no longer effective. However, the second-generation
anticoagulants difenacoum and bromadiolone can still be effective provided most rats in a population possess only a low
degree of resistance to them. Measures that maximize the uptake of bait, such as using the most palatable formulation,
baiting burrows and saturation baiting have to be implemented. The low levels of resistance discovered so far mean
that the most potent anticoagulants, such as brodifacoum and flocoumafen, should also control most populations if baits
containing either of them are properly applied. These two rodenticides are restricted to indoor use in the United
Kingdom and are thus not available to control those rats living outdoors that are highly resistant to all other
anticoagulants. Those rats can, however, be controlled with either zinc phosphide or calciferol, preferably after
prebaiting. Strategies to manage resistance in the long-term should be implemented before high-degree resistance
spreads. One potential tactic is to stop using anticoagulants altogether and allow deleterious pleiotropic effects to reduce
the prevalence of resistance in a population. Any attempts to manager resistance are only relevant if the intention is
to retain anticoagulant rodenticides, with their undoubted advantages, as the main method of controlling rodent pests.
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INTRODUCTION
Soon after the introduction in the United Kingdom
(UK) in 1975 of difenacoum, the first of the so-called
second-generation anticoagulant rodenticides introduced to
overcome warfarin resistance (Hadler and Buckle 1992),
reports were received from the county of Hampshire in
central southern England that it was failing to control
some Norway rat (Rattus norvegicus) populations
(Redfern and Gill 1978). However, these difenacoum-
resistant rats still appeared to be relatively susceptible to
difenacoum (resistance factor « 4), and therefore
resistance was not thought to be a serious practical
problem (Greaves and Cullen-Ayres 1988). It was
suggested that behavioral or ecological factors were
operating in this particular area that tended to reduce the
uptake of rodenticide bait and allowed these "slightly"
resistant animals to survive. Support for this idea came
in later studies (Quy, Shepherd and Inglis 1992; Quy et
al. 1992) in which the relatively greater abundance of
alternative food, particularly stored cereal, in the
Hampshire area was a relevant factor. Indeed, Quy,
Shepherd and Inglis (1992) suggested that earlier reports
(Greaves, Shepherd and Quy 1982) that resistance to two
other second-generation compounds, brodifacoum and
bromadiolone, was a main cause of treatment failure in
the Hampshire area, were premature. It might have been
that rats survived treatments largely because they ate little
or no bait, as demonstrated in later trials in the same area
(Cowan et al. 1995). Furthermore, because resistant rats
from Hampshire required more vitamin K than
susceptibles (Greaves and Cullen-Ayres 1988), resistant
individuals had a selective disadvantage. Withdrawal of
anticoagulants should result in resistant rats being
replaced, in due course, with susceptible ones, as
reported in earlier studies on warfarin resistance
(Partridge 1979). This could only occur, of course, if
susceptible alleles were present in the existing population
or in nearby reservoir populations.
Norway rats that are resistant to second-generation
anticoagulants have also been reported in other European
countries. A survey in 1992 reported difenacoum and
bromadiolone resistance in Denmark, France and
Germany with an additional report of bromadiolone
resistance in Holland (Myllymaki 1995). At the time of
the survey, no European country, other than the UK, had
reported resistance to brodifacoum or to two other
relatively new second-generation anticoagulants,
flocoumafen or difethialone (the latter not registered for
use in the UK). However, the author of the report doubts
that the full extent of anticoagulant resistance across
Europe was discovered, due to the limited facilities
available in most countries. In Germany, the area
infested by resistant rats appeared limited to about 8,000
sq. km in the northwest of the country with, apparently,
anticoagulant susceptible rats elsewhere (Pelz, Hanisch
and Lauenstein 1995). The authors suggested that
continued use of difenacoum and bromadiolone in the
resistance area might lead to further selection of genes
that conferred resistance to the most potent compounds.
Consequently, it was suggested that the resistant rats
should be controlled using the most potent anticoagulants,
brodifacoum, flocoumafen or difethialone.
In this paper, the practical aspects of dealing with
widespread resistance to second-generation anticoagulants
will be considered, including measures to counter the
problem in the short- and long-term, although at present
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long-term solutions are mostly speculative, because no
one has attempted to implement a rodenticide resistance
management strategy.
DEGREES OF RESISTANCE TO SECOND-
GENERATION ANTICOAGULANTS
The development of blood clotting response (BCR)
tests for detecting resistance to second-generation
coagulants (Gill et al. 1993, 1994) has enabled relatively
quick determination of resistance as well as sequential
testing of individual rats to identify how many different
anticoagulants they are resistant to. Buckle, Prescott and
Ward (1994) argued that because BCR tests are sensitive
enough to detect small shifts in susceptibility, they do not
necessarily predict a practical control problem. They
provide, however, the technology not only to distinguish
susceptible rats from resistant ones, but also to
differentiate between low- and high-degrees of resistance.
They have now become part of the resistance detection
methodology in many European countries (e.g., Pelz,
Hanisch and Lauenstein 1995). The distinction between
low- and high-degree resistance is not clear cut. Cowan
et al. (1995) divided rats into groups on the basis of their
response to difenacoum in BCR tests. Rats with log 10
PCA (percentage clotting activity) < 1 were susceptible,
1-1.5 had low-degree resistance, and >1.5 had high-
degree resistance. Animals in the latter group would
probably survive feeding on field strength baits for several
days. With those definitions, the Hampshire rat
populations in 1989 to 1992 contained, overall, 51% of
animals resistant to difenacoum (loglO PCA >1), but
only 22% with high-degree resistance (loglO PCA > 1.5).
The mean difenacoum PCA for 253 rats was 23.15 ±
1.53. There were insufficient animals tested to estimate
the prevalence and degree of bromadiolone resistance
among those populations, but from a sample of 19 rats,
the mean corrected PCA was 38.1 (loglO 1.58) ± 5.92.
The prevalence of warfarin resistance was 84%.
In contrast, most rats in a population discovered in
Berkshire, UK (Quy et al. 1995) were highly resistant to
both difenacoum (mean PCA 67.5 ± 4.3) and
bromadiolone (mean corrected PCA 107.9 ± 5.5).
Although some rats died on a 5- or 6-day no-choice
feeding test using 0.005% (w/w) bromadiolone, no rat
was classified as susceptible on any BCR test. From a
total of 50 rats given a bromadiolone BCR test over a
two-year period, only one was classified as having a low
degree of resistance; of 60 rats given a difenacoum BCR
test over the same period, two were found with low-
degree resistance. It was assumed that all rats were
warfarin-resistant.
In the UK up to 1995, populations containing rats
with some degree of resistance to difenacoum have been
found in central southern England and also the southeast
and east Midlands; bromadiolone-resistant rats have been
found in the central area of England between the south
coast and the Humber estuary (MacNicoll et al. 1996).
The authors also reported low-degree resistance
(determined by a feeding test) to brodifacoum in rats from
four farms in central southern England and a degree of
resistance to flocoumafen (by BCR test) in rats from one
farm. All the rats were tested after reports were received
of control problems on farms, so it is unclear whether
these were isolated incidents or that they reflected the
widespread nature of anticoagulant resistance in the UK.
Since 1995, rat populations have been sampled in new
areas without prior knowledge of control problems. Of
the 22 populations tested, 75% contained individuals
resistant to warfarin, 30% resistant to bromadiolone, and
5% resistant to difenacoum. The wide distribution of
populations containing resistant rats effectively rules out
any kind of containment operation, such as the one
instigated in the 1960s in an attempt (which failed) to
eliminate warfarin-resistant rats from an area along the
Anglo-Welsh border (Drummond 1966).
IDENTIFYING RESISTANCE AS A CAUSE OF
CONTROL FAILURE
The use of chemical markers to measure how much
bait individual rats consume in the field, together with
BCR tests to determine their resistance status, has enabled
detailed analysis of the reasons for poor control to be
carried out (Quy et al. 1992; Cowan et al. 1995; Quy et
al. 1995). It is now possible to establish the primary
cause of each treatment failure. Such techniques are not
immediately available to the occupier or pest control
operator who has to control an infestation, and they
would probably be seen as prohibitively expensive and a
cause of further delay in eradicating a problem. In those
situations, the only observations of treatment progress will
be bait take and the number of dead rats found.
Essentially, two problems are encountered whenever the
treatment appears to be failing—either little or no bait is
eaten, or bait is eaten but no dead rats are found. A poor
uptake of bait does not immediately signal resistance, but
it may be important if low-degree resistance is present
and the small amount eaten would otherwise kill fully
susceptible rats (Quy et al. 1996). In contrast to first-
generation anticoagulants, the increased potency of
second-generation compounds has meant that as rats may
acquire a lethal dose after one feeding, a continuous
supply of bait may not be necessary provided the rats are
not resistant, a concept know as "pulsed baiting" (Dubock
1984). The practical consequence is that bait points need
not be checked as frequently to maintain efficacy,
resulting in lower costs to the operator. Nevertheless,
where rats are resistant and the most palatable formulation
is being used, yet bait take is insufficient to kill, then
failure to control could be due to the combined effects of
poor bait take and resistance. If pulsed baiting is being
used, increasing the amount of bait to maintain a surplus
may give better results.
Where bait is readily consumed and there are
adequate numbers of bait points but no signs that rat
activity is decreasing, then resistance must be considered.
The warning dyes added to commercial rodenticide
formulations that color droppings are useful indicators
that rats are eating the bait. Bait eaten continuously from
particular points for longer than seven days should arouse
suspicion, whereas bait points reactivated after the same
time interval suggest probable reinvasion (Quy et al.
1994). It follows that bait points should be inspected two
to three times a week and records kept to avoid drawing
the wrong conclusions. In many cases, dead rats are
found and, if a sufficient number are killed to reduce the
infestation to below nuisance levels, the reason why some
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individuals have survived is likely to be seen as
immaterial.
Prior knowledge that the area contains warfarin-
resistant rats is important when second-generation
anticoagulants appear to be failing. It appears that a
prerequisite for the selection of resistance against the
more potent anticoagulants is the presence of warfarin-
resistant animals, which probably form a large proportion
of the population. Greaves, Shepherd and Gill (1982)
recorded a prevalence of 85 % warfarin resistance in the
first field investigation of difenacoum resistance in 1979-
80. Samples of rats in which all members survived a
warfarin feeding test were found in the USA in 1971
(Jackson and Kaukeinen 1972), but the resistant
populations were successfully controlled with zinc
phosphide, as second-generation anticoagulants were not
then available. Pelz, Hanisch and Lauenstein (1995)
reported a prevalence of 95.7% warfarin resistance on
two farms where bromadiolone and difenacoum resistance
was also present.
MANAGEMENT OF LOW-DEGREE RESISTANCE
The lack of alternative rodenticides with the same
attributes of practicability and relative safety as
anticoagulants means that, contrary to what one might
normally recommend for resistance management,
anticoagulants may still be the active ingredients of choice
provided the degree of resistance is low. The option to
use a non-anticoagulant, if one is available, is still there
and it has the advantage in that it would kill both resistant
and susceptible rats. Rather than withdraw all
anticoagulants, in some areas of the UK bromadiolone-
resistant rats can be controlled with difenacoum
(MacNicoll et al. 1996). If rats also become resistant to
that, then brodifacoum or flocoumafen are, subject to
restrictions, available. Only a small number of
populations have been identified that are bromadiolone-
resistant but difenacoum-susceptible. Although
bromadiolone baits appeared to be more successful than
difenacoum baits against resistant rats in Hampshire
(Greaves, Shepherd and Quy 1982), the difference
between the resistance factors towards the two compounds
(approximately two and four, respectively) was thought to
be of no practical consequence (Cowan et al. 1995). A
contributory factor to the apparently greater success of
bromadiolone baits might have been that baits containing
bromadiolone tend to be more palatable than those
containing difenacoum (Quy etal. 1996). Thus, rats with
a low-degree of resistance might have accumulated a
lethal does more quickly during the bromadiolone trials
than during the difenacoum trials. The aim in treating a
population with low-degree resistance would be to
maximize bait take by, for example, placing baits in
burrow entrances rather than containers—this technique
appears to be beneficial on sites with alternative food
sources (Quy et al. 1996). Unfortunately, this option is
not available if circumstances demand the use of tamper-
resistant bait stations. Moreover, a bait base acceptable
to the target population should be used. The advantage of
using potent compounds in less acceptable formulations,
such as wax blocks (Buckle 1994), to reduce non-target
risks, would be compromised. When three different
loose-grain baits, all containing bromadiolone, were tested
against warfarin-susceptible rats and rats with a low-
degree of resistance to difenacoum and bromadiolone, the
least palatable formulation was relatively unsuccessful at
controlling the resistant populations, although it did
eliminate the susceptible ones (CSL, unpubl.). The
availability of rodenticide concentrates would allow local
mixing of baits that maximize palatability and
consumption. Another detrimental aspect of controlling
rats with a low degree of resistance is a return to surplus
baiting, where previously minimal quantities of bait were
sufficient. Pulsed baiting (Dubock 1984) relies on the
high potency of anticoagulants such as brodifacoum and
flocoumafen to produce the same degree of control with
less bait and less labor input. The benefits in terms of
non-target risks are that there is a reduced amount of bait
available at any one time during a treatment. In taking
steps to maximize bait take to overcome low-degree
resistance, it must be recognized that risks to wildlife are
likely to increase.
Some rat populations in the Hampshire resistance area
contained individuals that had ingested doses of
difenacoum or bromadiolone in excess of 100 mg/kg body
weight and survived (Cowan et al. 1995) and might,
therefore, have been considered to be highly resistant.
Although these animals represented less than 1 % of the
survivors examined, the implication is that populations
containing predominately low-degree resistant animals,
may, nevertheless, contain a few highly resistant
individuals. This reinforces the need to carry out a
thorough treatment and kill all rats. However,
eliminating the last few survivors of a treatment could be
disproportionately costly and, on a busy farm, small
numbers of animals would probably be overlooked.
Further applications of these rodenticides against highly
resistant survivors and their descendants may eventually
produce a population that is completely refractory to
treatment. The fact that, to date, there have been no
reports of serious control failures, unequivocally due to
resistance, from the Hampshire area suggests either that
the selection pressure has not been sufficient, or that
highly resistant populations exist there, which are small
and not particularly troublesome, or are being controlled
by illegitimate means. When populations do become
troublesome and seem to be uncontrollable because of
high-degree resistance, the additional cost of alleviating
the problem may be substantial. It now appears that a
high-degree of resistance can be sustained within some
populations (Quy et al. 1995).
MANAGEMENT OF HIGH-DEGREE RESISTANCE
The success of anticoagulants, particularly second-
generation compounds, no doubt hastened the end of some
potentially useful non-anticoagulant toxicants. It seems
unlikely that more potent anticoagulants can be produced
to overcome the new forms of resistance that are now
appearing (Hadler and Buckle 1992). While it appears
that the most potent anticoagulants are still effective, for
all practical purposes, against all rat populations, both
brodifacoum and flocoumafen are registered for indoor
use only and for use by professional pest controllers only.
They are currently not available to control infestations of
rats resistant to difenacoum or bromadiolone, except in
those situations where indoor application of these
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rodenticides can control a population of rats that may live
mostly outdoors. Stopping the use of anticoagulants
would, in theory, reverse the selection pressure in favor
of susceptible rats. It might take some time for this to
happen, particularly if any deleterious effect did not
prevent individuals from breeding. In one example (Quy
et al. 1995), the descendants of survivors of a population
with a high-degree of resistance to bromadiolone and
difenacoum were tested after 17 months with apparently
no intervening exposure to anticoagulants. The degree
of resistance had reduced, but was still too high to
be confident of any success with difenacoum or
bromadiolone. It was likely that neighboring rat
populations, as potential sources of immigrants, were also
highly resistant to anticoagulant rodenticides, raising the
prospect that the occupier of the site may be unable to
achieve any satisfactory control for the foreseeable future
with those rodenticides. A further problem, foreseen by
Greaves (1994), is where a beneficial pleiotropic effect of
the resistance gene occurs which is maintained without
artificial selection. If that occurred, resistance would be
difficult to eliminate. The longer that resistant
populations are allowed to persist, the more likely it is
that mechanisms will evolve that dilute the pleiotropic
costs of resistance (Cowan et al. 1995).
Faced with a population of rats that could not be
controlled with second-generation anticoagulants for
reasons of resistance or legal restraints, Quy et al. (1995)
used calciferol, even though previous use of this
rodenticide had failed to alleviate the problem. The only
other option was zinc phosphide, which had also been
tried without success. Previous experience with both
compounds suggested that, to avoid inducing bait
aversions, a period of prebaiting would be needed to
maximize the effectiveness of the treatment, given the
possibility that a population of highly resistant rats, made
bait-shy by sublethal poisoning, could produce an
"unpoisonable" infestation.
The likelihood of persuading the majority of rats to
eat the prebait, wholly and continuously, hence improving
the chance of success with a relatively fast-acting poison,
may depend on the type of farm. The continual
disturbance that takes place in some farm habitats,
particularly those rearing livestock, appears to reduce
neophobic responses to bait and bait containers (Quy et al.
1994). In these situations, the prospects for substantial
reductions in rat numbers should be good, provided an
appropriate toxicant is available. The disadvantage,
however, is that when anticoagulants are used on livestock
farms, susceptible and partially resistant rats would be
quickly eliminated and a highly resistant population
selected, as Quy et al. (1995) observed on a pig farm. In
place of an unpoisoned prebait, a treatment could start
with an anticoagulant bait, which would kill any
susceptibles and could also become a prebait for an acute
poison such as zinc phosphide. It would be advisable to
ensure that the bait base of the anticoagulant formulation
was available to mix with the acute poison, as local
pesticide regulations might not allow two poisons to be
added together. As with any treatment with a fast-acting
toxicant, errors in bait placement could undermine
effectiveness and complete eradication would be unlikely.
The advantage of this approach for the occupier is that,
depending on the proportion of susceptible rats in the
population, the death of some rats might provide some
respite. The disadvantage is that, where there are very
few susceptible rats, anticoagulant formulations make
very costly prebaits.
Using a non-anticoagulant with prebaiting would
probably not require much more labor input man a
surplus-baiting anticoagulant treatment. However, such
treatments rarely kill all the rats, and a high percentage
reduction of a large population may still leave an
unacceptable number of survivors. This occurred
following the calciferol treatment reported by Quy et al.
(1995), and it required extensive trapping to remove the
residual infestation. It is noteworthy that the calciferol
formulation used in that trial, which was different to the
formulation first used on the farm, is not generally
available in the UK and is expensive. A relatively new,
non-anticoagulant rodenticide in the market place is
bromethalin, which is not registered for use in the UK.
Bromethalin requires no prebaiting as it does not
apparently cause bait-shyness (Jackson et al. 1982). The
development of alternative rodenticides is essential to help
slow down, at least, the evolution of widespread resistant
rat populations.
The use of non-anticoagulant rodenticides in "fire-
brigade" actions must be seen as a short-term measure,
alleviating urgent control problems. If there is a will to
retain anticoagulants for future use in rodent population
management, then strategies to control resistant rats in the
long-term must be put into practice. So far, this has not
occurred. Smith and Greaves (1987) considered
resistance management strategies and discussed the
theoretical and practical problems with their
implementation. One suggestion was the use of a
sterilizing agent to treat survivors of an anticoagulant
treatment, although a suitable chemical or
immunocontraceptive is currently not available. Earlier,
Lazarus and Rowe (1982) suggested incorporating a
similar agent into the prebait prior to an acute poison
treatment, after they had prevented an island rat
population from breeding for 10 months by using a
synthetic oestrogen. Methods that reduce rat populations
gradually over many months are not likely to be well
received by occupiers, but small numbers of animals
might be tolerated on farms, although probably not in
urban or industrial premises. Smith and Greaves (1987)
saw a potential advantage in allowing a small population
to remain, even if all members were resistant, because it
might repel immigrants for a time, thereby slowing down
reinfestation.
Should brodifacoum and other highly potent
anticoagulants be part of a long-term strategy to control
rats resistant to all other anticoagulants? For that to
happen, restrictions, where they apply, would have to be
relaxed and the potential consequences of non-target
hazards considered. Wider availability may result in the
evolution of populations of rats also resistant, for all
practical purposes, to those compounds. Rats with a low
degree of resistance to brodifacoum have already been
discovered (Gill and MacNicoll 1991). However, the use
of brodifacoum against rats resistant to warfarin, but not
to any other second-generation compound, might prevent
resistance to difenacoum or bromadiolone evolving almost
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indefinitely. Thus, in these circumstances, the advantages
of pulsed-baiting with brodifacoum, particularly the
reduced non-target risk, would remain.
In contrast to pesticide-dominated strategies to control
resistant rats, more environmentally-friendly methods may
become prominent if chemical control fails. Whatever the
resistance status of populations, techniques that reduce the
carrying capacity of a habitat, such as a farm, can
potentially reduce the scale of a control problem. Around
farm buildings and particularly in urban areas, reducing
harborage and denying access to food sources should be
possible without affecting populations of other animals.
Among field margins this is more problematic, and it has
been argued that selective destruction of a pest with a
pesticide is preferable (Howard 1967). Unfortunately,
this depends on a suitable pesticide being available.
Control without the use of anticoagulants would, of
course, remove the selection pressure towards increased
anticoagulant resistance.
CONCLUSIONS-IS RESISTANCE A PROBLEM?
The unusually large rat population reported by Quy et
al. (1995) was a consequence of a favorable habitat
combined with a failure to control with anticoagulant
rodenticides. The number of rats present reflected the
carrying capacity of a typical livestock farm in central,
southern England. Populations rarely increase to the
limits of the habitat, because control measures are usually
instigated long before such a limit is reached. With the
controversy surrounding the significance of resistance to
second-generation anticoagulants, it is difficult to present
any view that is not seen as biased by one party or
another. Manufacturers of rodenticides clearly do not like
their products to be criticized. Professional pest
controllers do not like to be accused of failing to provide
a satisfactory service. Legislators feel bound to respond
to public concerns about environmental safety and
humaneness. The public, presumably, still wants rats to
be controlled. Given the high costs of developing and
marketing a new rodenticide, it could be argued that
industry will take action when it is seen to be profitable.
By that time, the highly resistant populations, currently
limited to a small area in central, southern England, may
be distributed across the country. Smith and Greaves
(1987) emphasized the importance of resistance
monitoring and early action to eradicate resistant rats.
They also stressed the need to stop using anticoagulants
when resistance is detected. Although there is no routine
monitoring program in the UK, the development of
laboratory-based tests and extensive testing of rats from
field populations over the last 20 years has been an
invaluable and unique tool in understanding the nature of
rodent control problems.
The lack of alternative rodenticides is potentially
serious; a catalog for a well-known supplier of pest
control products in the UK lists 41 rodenticide
formulations for the control of rats, of which only two are
non-anticoagulants (both zinc phosphide). The danger
would be that, faced with an urgent need to control an
infestation, occupiers or their agents might resort to
unsafe or illegal methods to eradicate the rats if all
legitimate means failed. Jackson and Kaukeinen (1972)
reported that the farmers and pest control operators
depended on the use of anticoagulants to save tidying up
the farms to make them less attractive to rats. That view
appears to still be widely held. The effect of resistance
is probably insidious, only coming to people's attention
when other factors unrelated to resistance allow rat
population density to increase above what is regarded as
normal. Unfortunately, preventive action is hard to
justify to those who may be inconvenienced or put to
extra expense, when there is uncertainty about when or if
future control problems will arise.
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